Which diagnosis code should be used to order a plasma renin activity with reflex aldosterone test?

Diagnosis Codes for Ordering Plasma Renin Activity with Reflex Aldosterone

Use diagnosis codes for hypertension (essential or secondary) or suspected primary aldosteronism to order plasma renin activity with reflex aldosterone testing. The most appropriate codes include ICD-10 codes for essential hypertension (I10), secondary hypertension (I15.x), or disorders of adrenal gland (E27.x) when primary aldosteronism is suspected.

Clinical Context for Test Ordering

The plasma renin activity with reflex aldosterone test is specifically indicated for screening patients suspected of having primary aldosteronism, a condition that affects 5-12% of hypertensive patients 1, 2. The aldosterone-to-renin ratio (ARR) serves as the essential screening tool for this diagnosis 3, 4.

Specific Clinical Scenarios Warranting Testing

According to current guidelines, you should order this test for patients with:

• Resistant hypertension (hypertension requiring ≥3 antihypertensive medications or uncontrolled on treatment) 5, 6, 3
• Hypertension with hypokalemia (spontaneous or diuretic-induced) 3, 1
• Hypertension with adrenal incidentaloma discovered on imaging 1, 2
• Early-onset hypertension (age ≤40 years) or family history of early stroke 3
• Severe hypertension (BP ≥180/110 mmHg) 5, 6

Appropriate Diagnosis Codes

Primary Codes:

• I10 - Essential (primary) hypertension
• I15.0 - Renovascular hypertension
• I15.2 - Hypertension secondary to endocrine disorders
• I15.9 - Secondary hypertension, unspecified
• E26.0 - Primary hyperaldosteronism (if already suspected)
• E26.09 - Other primary hyperaldosteronism
• E26.9 - Hyperaldosteronism, unspecified
• E27.9 - Disorder of adrenal gland, unspecified

Supporting Codes:

• E87.6 - Hypokalemia (when present)
• R03.0 - Elevated blood pressure reading without diagnosis of hypertension

Critical Testing Considerations

Standardized collection conditions are mandatory 5, 6, 3, 4:

• Collect morning samples after patient has been sitting for at least 15 minutes
• Patient should have unrestricted salt intake and normal serum potassium 1, 2
• Withdraw interfering medications when possible:
  • Aldosterone antagonists (spironolactone, eplerenone) - hold ≥4 weeks 1, 2
  • Angiotensin receptor blockers - hold before testing 5, 6
  • Beta-blockers - hold before testing 5, 6
  • Clonidine - hold before testing 5, 6

Interpretation Thresholds

The most recent 2020 Canadian guidelines 3 provide assay-specific cut-offs:

For Plasma Renin Activity (PRA) method:

• ARR >555 pmol/L/ng/mL/h (higher sensitivity, lower specificity)
• ARR >750 pmol/L/ng/mL/h (lower sensitivity, higher specificity)

For Direct Renin Concentration (DRC) method:

• ARR >60 pmol/L/mIU/L (higher sensitivity)
• ARR >91 pmol/L/mIU/L (higher specificity)

The 2017 ACC/AHA guidelines 1, 2 recommend a cut-off of ARR >30 (when aldosterone is in ng/dL and PRA in ng/mL/h), with plasma aldosterone ≥10 ng/dL required to interpret the test as positive.

Common Pitfalls to Avoid

Do not order this test without proper patient preparation - failure to standardize collection conditions (posture, time of day, medication withdrawal) leads to false results 5, 6, 3.

Recognize that a positive screening test requires confirmatory testing before diagnosing primary aldosteronism 3, 1, 2, 4. Confirmatory options include saline suppression test, oral sodium loading test, or captopril suppression test.

Laboratory method matters significantly - the diagnostic accuracy of ARR calculated by direct renin concentration (DRC) may differ from plasma renin activity (PRA), with some evidence suggesting DRC provides higher specificity 7, 8, 9. Ensure your laboratory provides method-specific reference ranges.